JESSICA QUINLAN: Open Payments
NPI 1518529361 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,599 in 64 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $30 · 2025 $1,599
Food & beverage: $1,524Education: $75
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $143 |
| GENZYME CORPORATION | 1 | $125 |
| Daiichi Sankyo Inc. | 3 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $119 |
| Merck Sharp & Dohme LLC | 5 | $107 |
| Eisai Inc. | 4 | $79 |
| Celgene Corporation | 2 | $78 |
| ABBVIE INC. | 4 | $78 |
| PUMA BIOTECHNOLOGY, INC. | 4 | $77 |
| Incyte Corporation | 4 | $75 |
Products named: LIBTAYO, SARCLISA, Enhertu, KEYTRUDA, OPDIVO, FRUZAQLA, Lenvima, NERLYNX.
Industry payments across NY — which companies pay providers there.
